	Second Breast-Conserving Treatment for Ipsilateral Breast Tumor Recurrence: A Review of Patient Selection, Reirradiation Techniques, and Clinical Outcomes. Int J Cancer Cheptea C, Kirova Y, Mitrica RI, Badea M, Loap P. PMID: 42638516 [PubMed - as supplied by publisher]
	Immuno-PET imaging of mesothelin in ovarian cancer with (68)Ga-XH04: a first-in-human study. Biomark Res Deng Y, Zhang X, Pan Z, Lv X, Lin Z, Feng Y, Wu Z, Song X, Gai Y, Yin H, Zhu J, Jiang D, Lan X. PMID: 42638115 [PubMed]
	AI-based multimodal fusion for preoperative prediction of breast microcalcifications: combining mammography and tomosynthesis. BMC Med Imaging Wei J, Li J, Pan R, Cao M, Ma C, Xie Z, Ma Y, Gao Z. PMID: 42638095 [PubMed - indexed for MEDLINE]
	Interventional Radiology in the Management of Breast Cancer: Current Role and Future Directions. Cardiovasc Intervent Radiol Plastira C, Panourgias E, Chatziioannou A, Krokidis M. PMID: 42637827 [PubMed - as supplied by publisher]
	Metaplastic breast cancer: A single-centre retrospective experience. Surgeon Siddiky S, Nayeem SR, McLean NR, Youssef M, Humphreys A. PMID: 42637650 [PubMed - as supplied by publisher]
	Variation in chemotherapy delivery among patients with advanced epithelial ovarian cancer in the Netherlands and its association with survival: a nationwide cohort study. Int J Gynecol Cancer Said SA, Wenzel HHB, van Altena AM, Walraven JEW, IntHout J, de Hullu JA, van der Aa MA. PMID: 42637596 [PubMed - as supplied by publisher]
	Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial. Ann Oncol Garber JE, Cameron D, Campbell C, Yothers G, Taboada M, El-Abed S, Rastogi P, McConnell R, Correa A, Delaloge S, Liu WT, Sharma P, Bergh J, Janni W, Balmaña J, Loman N, , Friedman S, Freeman T, Armstrong A, Korde L, Im S, Sagara Y, Viale G, Bliss J, Gianni L, Jóhannsson Ó, Zoppoli G, De Dueñas EM, Marmé F, Fein L, Arnedos M, Ford J, Schmutzler R, Loibl S, Linderholm B, Lakhani SR, Gnant M, Gelmon K, Domchek SM, Senkus E, Eisen A, Jager A, Piccart M, Phillips KA, Traina T, Stickeler E, Singer CF, Shao Z, Liu X, Tipping H, Aktan G, Martinez M, Canon JL, Takahashi M, Yasojima H, Middleton K, Pristauz-Telsnigg G, Pfeiler G, Virani S, Valdes-Albini F, Wolmark N, Mesa ID, Paterson V, Gelber RD, Geyer CE Jr, Tutt ANJ. PMID: 42636977 [PubMed - as supplied by publisher]
	Triangulating evidence to evaluate selection bias in lifecourse Mendelian randomization studies: a practical framework illustrated by early-life adiposity and breast cancer. J Clin Epidemiol Power GM, Sanderson E, Gkatzionis A, Richardson TG, Tilling K, Smith GD, Hemani G. PMID: 42636914 [PubMed - as supplied by publisher]
	Efficacy of immediate lymphatic reconstruction after breast cancer surgery: A systematic review and time-course dynamics meta-analysis. J Reconstr Microsurg Chang HJ, Chen KY, Chiu WK, Hoang KD, Pai TW, Sun CY, Chen C. PMID: 42636877 [PubMed - as supplied by publisher]
	Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer. Lancet Oncol Macchia G, Morganti AG, Taylor A, Concin N, Oaknin A, Lorusso D, Vizzielli G, Nout R, González-Martín A, Pezzulla D, Deodato F, Herrera FG, Jereczek-Fossa BA, Guckenberger M. PMID: 42636843 [PubMed - indexed for MEDLINE]
	Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group. Lancet Oncol Gunster JLB, Tramm T, Machiels M, Demaria S, Formenti SC, de Caluwe A, Duane F, Klein J, Sur D, Somaiah N, Rakovitch E, Jerzak KJ, Lu FI, Hiley CT, Brackstone M, Ehinger A, Maley SK, Acs B, Zerdes I, Ozcan D, Khramtsov A, Salido E, Papathomas TG, Sharma P, Stecklein S, Khramtsova G, Horvath Z, Markov D, Hardas A, do Prado Moura JF, Ramirez A, Woodward WA, Sivapiragasam A, Denkert C, Michiels S, Loi S, Poortmans P, Mutter RW, Salgado R, Tran WT, International Immuno-Oncology Biomarker Working Group. PMID: 42636842 [PubMed - indexed for MEDLINE]
	Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study. Lancet Oncol Dixon-Douglas JR, Drubay D, Salgado R, Acs B, van der Laak J, Yuan Y, Amgad M, Cooper L, Hagos Y, AbdulJabbar K, Meakin J, van Ginneken B, Yan H, Lemonnier J, Penault-Llorca F, Lacroix-Triki M, Joensuu H, Kellokumpu-Lehtinen PL, Loibl S, Denkert C, Viale G, Colleoni MA, Sotiriou C, Piccart M, Dieci MV, Demaria S, Kammler R, Wolff AC, Sparano JA, Adams S, Badve S, Gray RJ, Curigliano G, Salomon AV, Nielsen TO, Pusztai L, Ciompi F, Michiels S, Loi S, International Immuno-Oncology Biomarker Working Group. PMID: 42636839 [PubMed - indexed for MEDLINE]
	Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial. Lancet Oncol Lara González LE, Giudici F, Salgado R, Yan H, Rojo F, Comerma L, Wienert S, Palacios J, Kos Z, de Haas SL, Rodriguez-Lescure A, Viale G, Zheng Y, Gao D, Kiermaier A, Andre F, Loibl S, Piccart MJ, Gelber R, Cameron D, Krop IE, Savas P, Nielsen TO, Denkert C, Michiels S, Loi S, APHINITY Steering Committee and Investigators and The International Immuno-Oncology Biomarker Working Group. PMID: 42636838 [PubMed - indexed for MEDLINE]
	Solid papillary carcinoma of the breast: A clinicopathological study with emphasis on unusual immunohistochemical and genetic features. Pathol Res Pract Hu B, Wang T, Yu J, Yan W. PMID: 42636673 [PubMed - as supplied by publisher]
	Based on Raman spectroscopy and clinical laboratory tests: Developing a fusion model to predict neoadjuvant therapy response in breast cancer. Transl Oncol Chen X, Li Z, Li Y, Chen Z, Song J, Wu H, Liu S, Li L, Li J. PMID: 42636655 [PubMed - as supplied by publisher]
	Ultrasound localisation microscopy predicts neoadjuvant chemotherapy response in patients with breast cancer. EBioMedicine Porte C, Kohlen M, Lisson T, Dencks S, von Stillfried S, Magnuska ZA, Winkler BS, Rix A, Koczera P, Boor P, Talbot SR, Schmitz G, Stickeler E, Kiessling F. PMID: 42636598 [PubMed - as supplied by publisher]
	CDK4/6i in the Underrepresented Histological Subtypes of HRÂ±/HER2- Metastatic Breast Cancer: A Real-World Cohort Study of Effectiveness and Safety. Clin Breast Cancer von Arx C, Calabrese A, Piezzo M, Di Lauro V, Martinelli C, Calderaio C, Tafuro M, Verrazzo A, Di Monda R, Magri E, Garigliota MLD, Di Filippo AM, Buonaiuto R, Buono G, Caputo R, Cianniello D, Cerillo I, Cocco S, Di Rienzo R, Nuzzo F, Pacilio C, Pagliuca M, Parola S, Pensabene M, Poggio F, De Angelis C, Del Mastro L, De Laurentiis M. PMID: 42636567 [PubMed - as supplied by publisher]
	Association of serratus anterior and pectoserratus plane blocks with persistent shoulder dysfunction after modified radical mastectomy in older breast cancer patients. J Clin Anesth Tokocin M, Olcum M, Cangoz K, Gundogdu A. PMID: 42636539 [PubMed - as supplied by publisher]
	Exome-based cancer driver gene comprehensive testing can provide a genetic diagnosis for individuals with triple-negative breast cancer. PLoS One Alzate D, Sánchez AY, Pacheco Y, Isaza Ruget M, Sánchez R, Castillo C, Parra-López CA. PMID: 42636242 [PubMed - indexed for MEDLINE]
	Ovarian Lymphoma and Bone Metastasis Presenting With Paraparesis in an Adolescent: A Case Report. Am J Case Rep Darajatun RH, Aditiyono A, Salima S. PMID: 42636191 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 334087

Page 1 of 16705



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy